Watch the full presentation below or navigate to the segments and questions that interest you the most.
Related Content

FY21 Strong financial performance, strategic transformation
26/04/2022
Instem has reported FY21 results consistent with the January trading statement and in line with our forecasts. Despite […]

Bringing drugs to market faster
25/02/2022
Instem offers an opportunity to invest in a business with two specific attractions – (1) The group is […]

Trading in-line, all key metrics improving
26/01/2022
Instem has delivered a positive trading update for the year to 31 December 2021, reporting like-for-like (LFL) revenue […]